NCT05211687

Brief Summary

Many patients with Parkinson's disease suffer of gait disorder termed as "freezing of gait" (FOG). non-pharmacological approach such as applying external cues is effective in mitigating FOG events. The aim of this study is to test the feasibility and patients satisfaction from a first stage of technology development, designed to deliver automatically external cues to the patients in their homes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2021

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

January 2, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 27, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

May 17, 2022

Status Verified

May 1, 2022

Enrollment Period

1.3 years

First QC Date

January 2, 2022

Last Update Submit

May 16, 2022

Conditions

Keywords

parkinson's diseaseFreezing of gaitSmart-home

Outcome Measures

Primary Outcomes (3)

  • Effect of smart-home technology on step length (cm)

    Step length (cm) is assessed during the three walking conditions in order to evaluate the effect of the cueing (visual and auditory) applied on gait. Data is collected by the Kinect sensor.

    through study completion, an average of 1 year

  • Effect of smart-home technology on step time (sec) are

    Step time (sec) is assessed during the three walking conditions in order to evaluate the effect of the cueing (visual and auditory) applied on gait. Data is collected by the Kinect sensor.

    Through study completion, an average of 1 year

  • Feasibility and participants' satisfaction semi-structured interview

    Following the walking session, participants answered questions in a semi-structured interview: 1. Did you see the light stripes clearly? (Yes/no) 2. Did you experience any discomfort while walking over the stripes? For example, did you feel dazzled? 3. Did you feel any change in your walking while using the light stripes? (Yes/no) 4. If you did feel any change, can you describe it in your own words? 5. Try to evaluate the magnitude of change in walking using the following visual scale (ranging from -5 to 5 will be presented to the particpants, -5 represent "Much worse", 0 represent "No change" and 5 represent "Much better) 6. Do you think that the light stripes would be effective for avoiding FOGs? Yes/No/ Maybe The same six questions are then asked about the metronome beats 7. Would you like to have such technology installed at your home? 8. If, yes, which kind of cues would you prefer (light stripe/ metronome)? 9. Do you have any suggestion for improvement?

    through study completion, an average of 1 year

Interventions

A projector, Kinect camera and computer are located 2 meters from the walking area. Participants walk nine times back and forth on the walking track, in each of three walking conditions: 1. Baseline: participants walk in a comfortable pace. The walking track consist a rectangle created by a white light projected on the floor. Based on in this walking condition, step width and cadence are calculated to determine the individual parameters of the cueing. 2. Light-stripes: The walking area consist of 4-5 white light-stripes. Space between the stripes is 110% of the participant step length. Participants are instructed to walk over the stripes. 3. Metronome: The walking track consist of a rectangle created by a white light projected on the floor, and in addition metronome beats are delivered by the computer. Beats frequency are 90% of the cadence. Participants are instructed to match their steps to the metronome beats. Each walking condition up to 90 seconds.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Poeple diagnosed with Parkinson's disease, living in the community

You may qualify if:

  • Patient is able to walk independently
  • The patient report on daily episodes of FOG as indicated by question #2 in the new FOG questionnaire ("How frequently do you experience freezing episodes?").
  • Score\>18 on the Telephone Version of the Mini-Mental State Examination (TMMSE)
  • Intact hearing and vision by self-declaration

You may not qualify if:

  • The patient suffer of any neurological condition other than Parkinson's disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Galit Yogev-Seligmann

Haifa, Please Select..., 3498838, Israel

RECRUITING

Related Publications (3)

  • Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes T, Giladi N. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. Gait Posture. 2009 Nov;30(4):459-63. doi: 10.1016/j.gaitpost.2009.07.108. Epub 2009 Aug 5.

    PMID: 19660949BACKGROUND
  • Keus HSJ, Munneke M, G. M. et al. European Physiotherapy Guidline for Parkinson's Disease. (2014).

    BACKGROUND
  • Yogev-Seligmann G, Josman N, Bitterman N, Rosenblum S, Naaman S, Gilboa Y. The development of a home-based technology to improve gait in people with Parkinson's disease: a feasibility study. Biomed Eng Online. 2023 Jan 19;22(1):2. doi: 10.1186/s12938-023-01066-2.

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Galit Yogev-Seligmann, PhD

    University of Haifa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Galit Yogev-Seligmann, PhD

CONTACT

Naomi Josman, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicipal Investigator

Study Record Dates

First Submitted

January 2, 2022

First Posted

January 27, 2022

Study Start

December 12, 2021

Primary Completion

March 30, 2023

Study Completion

June 30, 2023

Last Updated

May 17, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations